Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» remdesivir
remdesivir
Combo study of Gilead antiviral, Lilly anti-inflammatory drug positive in Covid-19, but raises pricing jitters
MedCity News
Wed, 09/16/20 - 07:47 pm
Eli Lilly
olumiant
Gilead Sciences
remdesivir
Veklury
drug pricing
COVID-19
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
Marketwatch
Mon, 09/14/20 - 10:21 am
Eli Lilly
Incyte
olumiant
COVID-19
remdesivir
Gilead Sciences
FDA extends remdesivir's emergency use authorization to all hospitalized COVID-19 patients
Beckers Hospital Review
Mon, 08/31/20 - 10:16 am
FDA
Gilead Sciences
remdesivir
COVID-19
Emergency Use Authorization
How Feds Decide On Remdesivir Shipments To States Remains Mysterious
NPR
Wed, 08/19/20 - 11:40 pm
Gilead Sciences
remdesivir
COVID-19
US to test benefits of remdesivir with second drug
Beckers Hospital Review
Tue, 08/18/20 - 11:02 am
Gilead Sciences
remdesivir
beta interferon
clinical trials
COVID-19
Researchers call out Gilead over diversity of remdesivir trials
Fierce Biotech
Wed, 08/12/20 - 12:20 pm
clinical trials
coronavirus
COVID-19
Gilead Sciences
remdesivir
racial disparity
Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir
Pharmaforum
Fri, 08/7/20 - 11:11 am
Pfizer
Gilead Sciences
remdesivir
COVID-19
pandemic
drug manufacturing
Gilead's COVID med remdesivir is scarce and costly, AGs say, urging feds to sidestep its patents
Fierce Pharma
Wed, 08/5/20 - 11:14 pm
Gilead Sciences
remdesivir
COVID-19
FDA
NIH
HHS
drug pricing
Covid-19 treatment: Gilead Sciences urged to study drug that showed promise with cats
The Guardian, UK
Wed, 08/5/20 - 12:05 am
GS-441524
Gilead Sciences
Public Citizen
COVID-19
remdesivir
Here's Gilead Sciences' Great COVID-19 Opportunity That You'll Really Want to Watch
Motley Fool
Tue, 07/14/20 - 10:36 am
Gilead Sciences
remdesivir
COVID-19
From Houston to Miami, hospitals running short of remdesivir for Covid-19 patients
Stat
Mon, 07/13/20 - 11:36 pm
Gilead Sciences
remdesivir
pandemic
COVID-19
Why Gilead Sciences' Successful COVID-19 Results Fell Flat
Motley Fool
Sun, 07/12/20 - 11:14 pm
Gilead Sciences
COVID-19
pandemic
remdesivir
Stocks Cut Losses After Gilead Says Remdesivir Coronavirus Treatment Reduces Risk Of Death
Forbes
Fri, 07/10/20 - 11:04 am
Gilead Sciences
pandemic
remdesivir
clinical trials
COVID-19
Gilead Covid-19 drug remdesivir benefited from $6.5B in NIH-funded basic research, study finds
MedCity News
Fri, 07/10/20 - 10:49 am
Gilead Sciences
remdesivir
NIH
COVID-19
Gilead Testing Inhaled Form Of Remdesivir That Could Be Used To Treat Covid-19 Outside Hospital
Forbes
Thu, 07/9/20 - 12:07 am
Gilead Sciences
remdesivir
COVID-19
pandemic
clinical trials
Gilead's long-awaited remdesivir price is $3,120, in line with watchdog estimates
Fierce Pharma
Mon, 06/29/20 - 10:46 am
drug pricing
Gilead Sciences
COVID-19
remdesivir
COVID-19 drug remdesivir recommended for EU approval
Pharmaforum
Fri, 06/26/20 - 09:43 am
Gilead
remdesivir
EMA
Europe
CHMP
COVID-19
Price for Gilead's COVID-19 drug should shrink if cheap steroid widely used, ICER says
BioPharma Dive
Thu, 06/25/20 - 07:25 pm
Gilead Sciences
remdesivir
ICER
drug pricing
steriod
Gilead to Test Inhaled Form of Remdesivir in COVID-19 Starting in August
BioSpace
Mon, 06/22/20 - 08:43 pm
Gilead Sciences
remdesivir
inhaled drugs
COVID-19
pandemic
clinical trials
Does Gilead Have a Cure for the Coronavirus?
Motley Fool
Sun, 06/21/20 - 11:02 pm
Gilead Sciences
remdesivir
COVID-19
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »